Atrapar 35 Gm
Information About Atrapar 35 Gm
About Atrapar 35 Gm
Medicine Brand Atrapar 35 gm is manufactured by Biomedica International and mainly contents the generic drug Atropine.
Pakaging
35 gm
Active Ingredients For Atrapar 35 Gm
Atropine 1
Diseases List For Which Atrapar 35 Gm Is Prescribed
This Drug Is Prescribed For Drying secretions reversal of excessive bradycardia with anticholinesterases for reversal of nondepolarising neuromuscular block antidote to organophosphorous poisoning
Other Significations For Atrapar 35 Gm
This Medication Belladonnaphenobarbital is an oral medication which combines naturally occurring belladonna alkaloids atropine scopolamine TransdermScop and hyoscyamine with phenobarbital It is used for treating abdominal discomfort that is thought to be due to muscular spasm of the intestinal muscles Belladonna alkaloids block the action of acetylcholine a chemical that nerves to use to communicate with other nerves and muscles Acetylcholine stimulates the muscles of the intestines that propels digesting food through the intestine It also affects the secretion of fluids by salivary glands and the stomach By blocking acetylcholine belladonna alkaloids relax intestinal muscles slow passage of digesting food through the intestines and reduce gastric secretion Phenobarbital produces sedation
Precautions To Be Taken Before Atrapar 35 Gm
Phenobarbital reduces the blood levels of several drugs by increasing their breakdown in the body Examples include voriconazole Vfend bocepravir Victrelis ranolazine Ranexa and protease inhibitors for example atazanavir Reyataz indinavir Crixivansaquinavir Invirase ritonavir Norvir Belladonnaphenobarbital should not be combined with potassium tablets because belladonnaphenobarbital slows the passage of potassium tablets through the gastrointestinal tract leading to potassiuminduced ulcers and high potassium levels in the blood
Major Conditions And Care
Pregnancy And Atrapar 35 Gm
Can We Take Atrapar 35 Gm During Pregnancy?
Pregnancy Class : D There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans but potential benefits may warrant use of the drug in pregnant women despite potential risks
Lactation And Atrapar 35 Gm
Can We Use Atrapar 35 Gm During Lactation
Lactation Class L4 There is positive evidence of risk to a breastfed infant or to breastmilk production but the benefits of use in breastfeeding mothers may be acceptable despite the risk to the infant eg if the drug is needed in a lifethreatening situation or for a serious disease for which safer drugs cannot be used or are ineffective
Side Effects Of Atrapar 35 Gm
Nausea stomach upset skin rash acute toxicity